Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemo-Radiation-Induced Abscopal Effect in Metastatic Solid Tumors
NCT02474186Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Apr 2003
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of sargramostim in breast cancer, solid tumor, sponsored by NYU Langone Health. Started Apr 2003; status: completed.
02
Drugs
sargramostim
03
Conditions
breast cancersolid tumor
Beyond the preview
Go deeper on NCT02474186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474186.